A large portion of the prescription medication American’s consume are generic. But with many of the active ingredients being sourced and manufactured in other countries, are our federal oversights enough protection? This week, our expert explains the systems in place – as well as their weaknesses and strengths.
Guest Information:
- Dr. Rena Conti, Associate Professor of Markets, Public Policy, and Law, Boston University Questrom School of Business
Leave a Reply